NF-kappa B Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
Author:
|
Kircheis, Ralf; Haasbach, Emanuel; Lueftenegger, Daniel; Heyken, Willm T.; Ocker, Matthias; Planz, Oliver
|
Tübinger Autor(en):
|
|
Published in:
|
Frontiers in Immunology
(2020), Bd.
11,
Article 598444
|
Verlagsangabe:
|
Frontiers Media Sa
|
Language:
|
English
|
Full text:
|
http://dx.doi.org/10.3389/fimmu.2020.598444
|
ISSN:
|
1664-3224
|
DDC Classifikation:
|
570 - Life sciences; biology 610 - Medicine and health
|
Dokumentart:
|
Article
|
Show full item record
|